|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 39/12 | (2006.01) |
| A61K2039/55505 | (2013.01) | ||
| A61K 31/047 | (2006.01) | ||
| C12N2740/16134 | (2013.01) | ||
| A61K 31/198 | (2006.01) | ||
| A61K 33/06 | (2013.01) | ||
| A61K 9/0019 | (2013.01) | ||
| A61K 47/26 | (2013.01) | ||
| A61K 9/08 | (2013.01) | ||
| A61K 39/12 | (2013.01) | ||
| A61K 31/047 | (2013.01) | ||
| A61K 31/198 | (2013.01) | ||
| A61P 31/18 | (2018.01) | ||
| A61P 37/04 | (2018.01) | ||
| A61K 39/00 | (2013.01) |
| (11) | Number of the document | 3471765 |
| (13) | Kind of document | T |
| (96) | European patent application number | 17731855.7 |
| Date of filing the European patent application | 2017-06-15 | |
| (97) | Date of publication of the European application | 2019-04-24 |
| (45) | Date of publication and mention of the grant of the patent | 2024-04-24 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/EP2017/064665 |
| Date | 2017-06-15 |
| (87) | Number | WO 2017/216288 |
| Date | 2017-12-21 |
| (30) | Number | Date | Country code |
| 201662350919 P | 2016-06-16 | US |
| (72) |
NGUYEN, Thierry-Thien , NL
BRUNER, Mark , NL
|
| (73) |
Janssen Vaccines & Prevention B.V. ,
Archimedesweg 4, 2333 CN Leiden,
NL
|
| (54) | HIV VACCINE FORMULATION |
| HIV VACCINE FORMULATION |